At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.
Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.


Latest News

GrayBug to Participate in 7th Ocular Diseases Drug Discovery Conference

March 17, 2015

Co-founder and CSO Dr. Justin Hanes to deliver keynote presentation President & CEO Michael O’Rourke to speak on panel BALTIMORE (March 17, 2015) – GrayBug Inc., a privately held pharmaceutical…

More News